T 1350/11 (Orally administered immunoglobulins for the treatment of immune disorders/LAURIDSEN) of 02.07.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T135011.20150702
- Date of decision
- 2 July 2015
- Case number
- T 1350/11
- Petition for review of
- -
- Application number
- 02733789.8
- IPC class
- A61K 39/00A61P 37/00A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods and compositions for treatment of immune dysfunction disorders
- Applicant name
- The Lauridsen Group Incorporated
- Opponent name
- -
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 83European Patent Convention R 115(2)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(3)Rules of procedure of the Boards of Appeal Art 15(3)
- Keywords
- Sufficiency of disclosure - of all requests (no)
- Catchword
- -
- Cited cases
- T 0609/02
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.